Agam Khare is the Founder and CEO at Absolute, one of the worldʼs leading plant bioscience companies leveraging the best of nature, science and exponential technologies to build a better future for the planet.
Khare serves on the Scientific Advisory Council of Tata Transformation Prize run by New York Academy of Sciences and this week is in the UK to address the Cambridge University Technology and Enterprise Club (CUTEC) launch event at the University of Cambridge.
“We are based out of India and we operate in 16 countries, working across agriculture, biomaterial and healthcare space,” Khare told India Global Forum (IGF) recently.
“It can’t be a better time than today to be building a global company, especially out of India which reaches out to the world and transforms the world for ever,” he said.
MORE LIKE THIS…
Absolute leverages billions of years of nature's intelligence to solve humanity's grandest challenges. It is powered by cutting-edge research at Xenesis Institute, its R&D arm, and comprehensive data captured on Xenesis’s proprietary Nature Intelligence Platform. With a team of over 500 individuals, including 150 scientists, Absolute's bioscience solutions have spread across five continents, positively impacting more than 1.1 million lives. Its founder is a part of the Young India Philanthropic Pledge (YIPP), where he has pledged 25 per cent of his wealth towards humanitarian causes.
Absolute, backed by Sequoia Capital, Tiger Global, Falcon Edge (AWI) including several prominent billionaires who recently raised $100 million, is an Indian start-up leveraging the power of nature, science, and exponential innovations to create a sustainable future for all.
MORE LIKE THIS…
Khare is passionate about innovations emerging in biotech, brain machine interface, space tech and global commerce. He firmly believes that the next generation of frontier tech companies will emerge by intersecting the best in Artificial Intelligence and Nature Intelligence. He also advises several start-ups and universities across Asia, Europe and the US.
